Pancreatic nodal metastases: Biologic significance and therapeutic considerations

C. J. Yeo, John L Cameron

Research output: Contribution to journalArticle

Abstract

Adenocarcinomas of the pancreas remains a disease in which the majority of patients succumb to the neoplastic process, even after potentially curative resection. There has been an overall improvement in patient outcome in recent years, partially explicable by the increasing safety of pancreaticoduodenal resection. Factors have been identified as being important in long-term survival include diploid tumor DNA content, small tumor size, absence of lymph node metastases, and resection with negative resection margins. Another factor that appears to favor long-term survival is the use of postoperative combined modality chemoradiation therapy. Clearly, newer treatment modalities should be evaluated in the hope of improving outcome. Additionally, developments in earlier detection and staging, via applications from the field of molecular genetics, may provide further improvements in outcome.

Original languageEnglish (US)
Pages (from-to)145-157
Number of pages13
JournalSurgical Oncology Clinics of North America
Volume5
Issue number1
StatePublished - 1996

Fingerprint

Neoplasm Metastasis
Neoplastic Processes
Combined Modality Therapy
Survival
Diploidy
Molecular Biology
Pancreas
Neoplasms
Adenocarcinoma
Lymph Nodes
Safety
DNA
Therapeutics
Margins of Excision

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Pancreatic nodal metastases : Biologic significance and therapeutic considerations. / Yeo, C. J.; Cameron, John L.

In: Surgical Oncology Clinics of North America, Vol. 5, No. 1, 1996, p. 145-157.

Research output: Contribution to journalArticle

@article{8d4dddae920c4c64b2abd76fd312cc2f,
title = "Pancreatic nodal metastases: Biologic significance and therapeutic considerations",
abstract = "Adenocarcinomas of the pancreas remains a disease in which the majority of patients succumb to the neoplastic process, even after potentially curative resection. There has been an overall improvement in patient outcome in recent years, partially explicable by the increasing safety of pancreaticoduodenal resection. Factors have been identified as being important in long-term survival include diploid tumor DNA content, small tumor size, absence of lymph node metastases, and resection with negative resection margins. Another factor that appears to favor long-term survival is the use of postoperative combined modality chemoradiation therapy. Clearly, newer treatment modalities should be evaluated in the hope of improving outcome. Additionally, developments in earlier detection and staging, via applications from the field of molecular genetics, may provide further improvements in outcome.",
author = "Yeo, {C. J.} and Cameron, {John L}",
year = "1996",
language = "English (US)",
volume = "5",
pages = "145--157",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pancreatic nodal metastases

T2 - Biologic significance and therapeutic considerations

AU - Yeo, C. J.

AU - Cameron, John L

PY - 1996

Y1 - 1996

N2 - Adenocarcinomas of the pancreas remains a disease in which the majority of patients succumb to the neoplastic process, even after potentially curative resection. There has been an overall improvement in patient outcome in recent years, partially explicable by the increasing safety of pancreaticoduodenal resection. Factors have been identified as being important in long-term survival include diploid tumor DNA content, small tumor size, absence of lymph node metastases, and resection with negative resection margins. Another factor that appears to favor long-term survival is the use of postoperative combined modality chemoradiation therapy. Clearly, newer treatment modalities should be evaluated in the hope of improving outcome. Additionally, developments in earlier detection and staging, via applications from the field of molecular genetics, may provide further improvements in outcome.

AB - Adenocarcinomas of the pancreas remains a disease in which the majority of patients succumb to the neoplastic process, even after potentially curative resection. There has been an overall improvement in patient outcome in recent years, partially explicable by the increasing safety of pancreaticoduodenal resection. Factors have been identified as being important in long-term survival include diploid tumor DNA content, small tumor size, absence of lymph node metastases, and resection with negative resection margins. Another factor that appears to favor long-term survival is the use of postoperative combined modality chemoradiation therapy. Clearly, newer treatment modalities should be evaluated in the hope of improving outcome. Additionally, developments in earlier detection and staging, via applications from the field of molecular genetics, may provide further improvements in outcome.

UR - http://www.scopus.com/inward/record.url?scp=0030067982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030067982&partnerID=8YFLogxK

M3 - Article

C2 - 8789499

AN - SCOPUS:0030067982

VL - 5

SP - 145

EP - 157

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -